Damato, Erika <br/><br/>
Plasma exchange and rituximab in the management of acute occlusive retinal vasculopathy secondary to systemic lupus erythematosus.  [electronic resource] 

 -  Ocular immunology and inflammation  Oct 2011 
 - 379-81 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1744-5078 
<br/><br/><label>Standard No.: </label>10.3109/09273948.2011.603069  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Female<br/>Fluorescein Angiography<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Lupus Vasculitis, Central Nervous System--complications<br/>Methylprednisolone--therapeutic use<br/>Mycophenolic Acid--analogs & derivatives<br/>Neuroprotective Agents--therapeutic use<br/>Plasma Exchange<br/>Prednisolone--therapeutic use<br/>Retinal Artery Occlusion--drug therapy<br/>Retinal Vasculitis--therapy<br/>Rituximab<br/>Treatment Outcome<br/>Visual Acuity--drug effects